Related Experiment Video
Updated: Aug 9, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
CDC25 phosphatases as potential human oncogenes
K Galaktionov1, A K Lee, J Eckstein
1Howard Hughes Medical Institute, Cold Spring Harbor Laboratory, NY 11724, USA.
Abstract:
Cyclin-dependent kinases (CDKs) are activated by CDC25 phosphatases, which remove inhibitory phosphate from tyrosine and threonine residues. In human cells, CDC25 proteins are encoded by a multigene family, consisting of CDC25A, CDC25B, and CDC25C. In rodent cells, human CDC25A or CDC25B but not CDC25C phosphatases cooperate with either Ha-RASG12V or loss of RB1 in oncogenic focus formation. Such transformants were highly aneuploid, grew in soft agar, and formed high-grade tumors in nude mice. Overexpression of CDC25B was detected in 32 percent of human primary breast cancers tested. The CDC25 phosphatases may contribute to the development of human cancer.
Insights
CDC25 phosphatases activate cyclin-dependent kinases (CDKs). CDC25B overexpression in human breast cancers suggests CDC25 phosphatases contribute to human cancer development.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Cyclin-dependent kinases (CDKs) regulate the cell cycle.
- CDC25 phosphatases activate CDKs by removing inhibitory phosphates.
- The human CDC25 gene family includes CDC25A, CDC25B, and CDC25C.
Purpose of the Study:
- To investigate the role of CDC25 phosphatases in oncogenic transformation.
- To determine if CDC25 phosphatases contribute to human cancer development.
Main Methods:
- Assessing oncogenic focus formation in rodent cells using human CDC25A, CDC25B, or CDC25C.
- Introducing oncogenic Ha-RASG12V or RB1 loss.
- Analyzing tumor characteristics in mice.
- Quantifying CDC25B expression in human breast cancer samples.
Main Results:
- Human CDC25A and CDC25B, but not CDC25C, cooperated with Ha-RASG12V or RB1 loss to form oncogenic foci in rodent cells.
- Transformed cells exhibited aneuploidy, soft agar growth, and formed high-grade tumors in nude mice.
- CDC25B was overexpressed in 32% of human primary breast cancers.
Conclusions:
- CDC25A and CDC25B phosphatases can promote oncogenic transformation.
- CDC25B overexpression in breast cancer suggests a role in human tumorigenesis.
- CDC25 phosphatases are potential contributors to human cancer development.
Related Concept Videos
Positive Regulator Molecules
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

